COVID symptoms this summer look a lot like symptoms from earlier strains, such as fatigue, runny nose and a headache. “The COVID symptoms that I’m seeing in clinic aren’t any different this year than ...

The interview with Dr Asad Khan on long Covid (Solidarity 747-748) highlights the contribution to the growth in mental ill-health of widespread long Covid, which affects hundreds of millions of ...

These five blue-chip dividend stocks have had a tough 2025 but are solid long-term buys for growth and income investors.

Here are five high-yield dividend stocks that offer passive income and solid entry points that investors can buy and forget ...

COVID-19 cases are rising in 26 states. Is the US in a summer wave? What to know about COVID trends and symptoms of the new ...

The condition known as long COVID may be more common than people think, according to a new study led by Oregon Health & Science University researchers.

Bay Area researchers created a group of AI “scientists” that proposed a potential COVID treatment. They say the approach ...

Yonker is a co-inventor on a patent for zonulin antagonists to treat MIS-C, as are two other co-authors. Co-authors also ...

There have been lots of changes to COVID vaccine recommendations. Here is the current vaccine schedule for people 6 months to 65+ years old.

In a small trial, Mass General Brigham researchers have found that a drug designed to treat celiac disease supported a more rapid return to normal activities for patients following COVID.

Janus kinase (JAK) inhibitors are associated with decreased mortality and fewer serious adverse events among adults hospitalized with COVID-19.